Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Recent & Breaking News (NYSE:PFE)

Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer

Business Wire March 3, 2016

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

Business Wire March 1, 2016

ViiV Healthcare Announces First Phase II HIV Prevention Study Results for Investigational Long-acting Injectable Cabotegravir

PR Newswire February 24, 2016

Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis

Business Wire February 24, 2016

ViiV Healthcare Announces Phase II Study Results for First Two Drug, Long-acting Injectable Regimen for HIV-1 Treatment

PR Newswire February 23, 2016

GSK's Global HIV Business ViiV Healthcare Completes Transactions to Acquire Bristol-Myers Squibb's R&D HIV Assets

PR Newswire February 22, 2016

Slump Could Be Healthcare ETF Buying Opportunity

Benzinga.com  February 22, 2016

Pfizer Receives Expanded FDA Approval For IBRANCE (palbociclib) In HR+, HER2- Metastatic Breast Cancer

Business Wire February 19, 2016

13F from Cooperman's Omega Shows Reduced Stakes in Anadarko, Facebook, Motorola Solutions, Pfizer, Time Warner

Press Releases February 16, 2016

13F from JANA Shows New ~9.17M Share Stake in Pfizer

Press Releases February 16, 2016

Pfizer Reaches Agreement to Resolve Medicaid Protonix Claims, Wyeth to Make ~785M Payment

Press Releases February 16, 2016

UPDATE: Wyeth to Make Payment of $784.6M to Resolve Claims

Press Releases February 16, 2016

WYETH REACHES AGREEMENT IN PRINCIPLE TO RESOLVE MEDICAID DRUG REBATE CLAIMS FOR 2001-2006 PERIOD FOR PROTONIX

Press Releases February 16, 2016

Pfizer Commends The FDA Advisory Committee's Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications

Business Wire February 9, 2016

How To Invest In An Aging World With The 'Live Long & Prosper' ETF

Benzinga.com  February 8, 2016

Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction

Business Wire February 8, 2016

A Checkup On A Big Healthcare ETF

Benzinga.com  February 5, 2016

Finding Value Inside Opportunity - Analyst Notes on Pfizer, Lowe's Companies, Starbucks and Boeing

Accesswire February 4, 2016

Joe McCann: Here's How To Play Biotech Market In Earnings Season

Benzinga.com  February 3, 2016

PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2015 RESULTS

Business Wire February 2, 2016